HAVN Life Enters into Distribution Agreement with Mycrodose Therapeutics for U.S....

Optimi Health Approved to Supply Psilocybin Under Health Canada’s Special Access...

Trauma and Vulnerability to Suggestion: Redefining How We Understand Consent

COMPASS Pathways plc to announce fourth quarter and full year 2021...

Awakn Files Patent For A New Class Of Entactogen-Like Molecules

Mindset Pharma Identifies New Pharmacological Insights of First Generation Psychedelics Through...

Entheon Biomedical Partners with Wavepaths on Upcoming Observational Study

PharmaTher Announces Grant of U.S. Patent on Ketamine Formulation

Nova Mentis Study Confirms Oral Microdose Psilocybin Treatment of Autism

Mydecine Announces MYCO-005 Family of Improved Safety Microdose Novel Molecules

Load more